Generic Mifepristone Maker Sues To Enjoin Any Status Change Without Due Process

(April 21, 2023, 1:04 PM EDT) -- GREENBELT, Md. — A generic drug manufacturer filed a civil complaint against the Food and Drug Administration and the Department of Justice to enjoin them from changing the approval of mifepristone or to bring any enforcement action, including bringing any criminal charges for distributing a misbranded drug, without affording the manufacturer due process....

Attached Documents

Related Sections